Skip to main content

Table 2 Univariate and multivariate analysis for the identification of predictive factors of recurrence

From: Is adjuvant chemotherapy necessary in pT1N1 gastric cancer?

 

Univariate analysis

Multivariate analysis

 

HR

95% CI

P

HR

95% CI

P

Age

  ≤ 65

      

  > 65

2.625

1.384–4.981

0.003

2.541

1.336–4.831

0.004

Gender

 Female

      

 Male

2.401

1.101–5.240

0.028

2.217

1.013–4.854

0.046

BMI (kg/m2)

  ≥ 25

      

  < 25

2.599

1.086–6.216

0.032

2.400

1.001–5.759

0.050

Type of resection

 Subtotal

      

 Total

0.718

0.221–2.334

0.581

   

Tumor location

 Upper

      

 Middle

0.871

0.193–3.932

0.857

   

 Lower

1.167

0.276–4.928

0.834

   

Gross type

 Non-elevated

      

 Elevated

2.063

1.054–4.037

0.035

1.821

0.929–3.570

0.081

Depth of invasion

 Mucosa

      

 Submucosa

3.464

0.834–14.394

0.087

   

No. of metastatic LN

 One

      

 Two

1.194

0.623–2.288

0.594

   

No. of negative LN

0.996

0.975–1.017

0.697

   

Lymphatic invasion

 Negative

      

 Positive

1.800

0.939–3.454

0.077

   

Histologic type

 Undifferentiated

      

 Differentiated

2.251

1.163–4.356

0.016

1.548

0.776–3.087

0.215

Adjuvant CTx

 No

      

 Yes

0.919

0.455–1.859

0.815

0.952

0.467–1.937

0.891

  1. BMI body mass index, CI confidence interval, CTx chemotherapy, HR hazard ratio, LN lymph nodes, LVI lymphovascular invasion
  2. P-value was italicized when less than 0.05